McClung, Michael R.

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

Cummings, S. R., Martin, J. S., McClung, M. R., Siris, E. S., Eastell, R., Reid, I. R., Delmas, P., Zoog, H. B., Austin, M., Wang, A., et al. (2009) · New England Journal of Medicine

Bone health and osteoporosis researchBone Metabolism and Diseases

Cited by 3,489

Osteoporosis

Compston, J. E., McClung, M. R., & Leslie, W. D. (2019) · The Lancet

Bone health and osteoporosis researchBone health and treatments

Cited by 2,449

Effect of Risedronate on the Risk of Hip Fracture in Elderly Women

McClung, M. R., Geusens, P., Miller, P. D., Zippel, H., Bensen, W. G., Roux, C., Adami, S., Fogelman, I., Diamond, T., Eastell, R., et al. (2001) · New England Journal of Medicine

Bone health and osteoporosis researchHip and Femur Fractures

Cited by 1,918

Romosozumab in Postmenopausal Women with Low Bone Mineral Density

McClung, M. R., Grauer, A., Boonen, S., Bolognese, M. A., Brown, J. P., Diez-Perez, A., Langdahl, B. L., Reginster, J.-Y., Zanchetta, J. R., Wasserman, S. M., et al. (2014) · New England Journal of Medicine

Bone health and osteoporosis researchBone health and treatments

Cited by 1,258

Denosumab in postmenopausal women with low bone mineral density.

McClung, M. R., Lewiecki, E. M., Cohen, S. B., Bolognese, M. A., Woodson, G. C., Moffett, A. H., Peacock, M., Miller, P. D., Lederman, S. N., Chesnut, C. H., et al. (2006) · New England Journal of Medicine

Bone health and osteoporosis researchBone health and treatments

Cited by 1,228

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards

for the IOF-IFCC Bone Marker Standards Working Group, Vasikaran, S., Eastell, R., Bruyère, O., Foldes, A. J., Garnero, P., Griesmacher, A., McClung, M., Morris, H. A., Silverman, S., et al. (2011) · Osteoporosis International

Bone health and osteoporosis researchBone health and treatments

Cited by 1,212

American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update

Camacho, P. M., Petak, S. M., Binkley, N., Diab, D. L., Eldeiry, L. S., Farooki, A., Harris, S. T., Hurley, D. L., Kelly, J., Lewiecki, E. M., et al. (2020) · Endocrine Practice

Bone health and osteoporosis researchMenopause: Health Impacts and Treatments

Cited by 1,182

Monthly Oral Ibandronate Therapy in Postmenopausal Osteoporosis: 1-Year Results From the MOBILE Study

Miller, P. D., Mcclung, M. R., Macovei, L., Stakkestad, J. A., Luckey, M., Bonvoisin, B., Reginster, J.-Y., Recker, R. R., Hughes, C., Lewiecki, E. M., et al. (2005) · Journal of Bone and Mineral Research

Bone health and osteoporosis researchBone health and treatments

Cited by 333

Two-Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD

Lewiecki, E. M., Miller, P. D., McClung, M. R., Cohen, S. B., Bolognese, M. A., Liu, Y., Wang, A., Siddhanti, S., & Fitzpatrick, L. A. (2007) · Journal of Bone and Mineral Research

Bone health and osteoporosis researchBone health and treatments

Cited by 319

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

McClung, M. R., O'Donoghue, M. L., Papapoulos, S. E., Bone, H., Langdahl, B., Saag, K. G., Reid, I. R., Kiel, D. P., Cavallari, I., Bonaca, M. P., et al. (2019) · The Lancet Diabetes & Endocrinology

Bone health and osteoporosis researchMenopause: Health Impacts and Treatments

Cited by 169

Romosozumab for the treatment of osteoporosis

McClung, M. R. (2018) · Osteoporosis and Sarcopenia

Bone health and osteoporosis researchBone Metabolism and Diseases

Cited by 78

The relationship between bone mineral density and fracture risk

McClung, M. R. (2005) · Current Osteoporosis Reports

Bone health and osteoporosis researchMenopause: Health Impacts and Treatments

Cited by 77

Effects of Pioglitazone on Bone in Postmenopausal Women With Impaired Fasting Glucose or Impaired Glucose Tolerance: A Randomized, Double-Blind, Placebo-Controlled Study

Bone, H. G., Lindsay, R., McClung, M. R., Perez, A. T., Raanan, M. G., & Spanheimer, R. G. (2013) · The Journal of Clinical Endocrinology & Metabolism

Bone health and osteoporosis researchDiabetes Treatment and Management

Cited by 47